|
시장보고서
상품코드
2053171
약물 중독 치료 시장 : 치료법별, 투여 경로별, 최종 사용자별, 지역별Drug Addiction Treatment Market, By Treatment, By Route of Administration, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
약물 중독 치료 시장은 2026년에 204억 달러에 달하고, 2033년까지 339억 8,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 7.6%를 나타낼 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 204억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 7.60% | 예측 금액(2033년) | 339억 8,000만 달러 |
세계 약물 중독 치료 시장은 전 세계 선진국 및 개발도상국에서 약물 남용이 증가함에 따라 최근 꾸준히 성장하고 있습니다. 2021년 6월, 유엔 마약범죄사무소(UNODC)에 따르면, 2021년에는 전 세계적으로 약 2억 6,900만 명이 적어도 한 번 이상 마약을 사용한 것으로 나타났습니다. 불법 약물을 쉽게 구할 수 있다는 점에 더해, 사회경제적 취약성이 겹치면서 약물 의존의 위험을 현저히 가중시키고 있습니다. 이에 대해 각국 정부는 개인이 약물 사용 장애를 극복할 수 있도록, 증거에 기반한 치료 서비스를 제공하는 노력을 강화하고 있습니다. 이것이 세계 약물 의존 치료 시장에서 다양한 약리학적 및 심리학적 의존 치료제와 치료법에 대한 수요를 주로 견인하고 있습니다.
시장 역학
세계 약물 중독 치료 시장의 성장을 견인하는 주요 요인으로는 약물 남용 장애를 범죄의 대상이 아닌 치료가 필요한 의학적 질환으로 사회적으로 수용하려는 경향이 높아지고 있는 점, 치료 시설 확충을 위한 정부의 의료비 지출 증가, 그리고 오피오이드 위기의 원인 중 하나인 오피오이드 진통제 사용자 증가 등이 있습니다. 그러나 해독 치료 후의 사회적 지원 프로그램 부족, 약물 남용 치료에 따르는 낙인, 그리고 중독 치료에 대한 전문 교육을 받은 의료진의 부족과 같은 요인들이 시장 관계자들에게 과제로 대두되고 있습니다. 한편, 안전성과 유효성 프로파일이 개선된 신약에 대한 연구가 지속되고 있으며, 상담 프로그램에 디지털 기술을 도입하는 것은 이해관계자들에게 큰 성장 기회를 제공합니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 분석도 제공합니다.
- 전 세계 약물 중독 치료 시장의 주요 기업 프로파일을 다양한 지표(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등)를 바탕으로 소개합니다.
- 본 보고서의 인사이트를 바탕으로 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제품 라인업 개편, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계의 약물 중독 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자는 세계의 약물 중독 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 약물 중독 치료 시장 : 유형별(2021-2033년)
제5장 세계의 약물 중독 치료 시장 : 치료법별(2021-2033년)
제6장 세계의 약물 중독 치료 시장 : 투여 경로별(2021-2033년)
제7장 세계의 약물 중독 치료 시장 : 최종 사용자별(2021-2033년)
제8장 세계의 약물 중독 치료 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 분석 방법
KTH 26.06.17Drug Addiction Treatment Market is estimated to be valued at USD 20.40 Bn in 2026 and is expected to reach USD 33.98 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 20.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.60% | 2033 Value Projection: | USD 33.98 Bn |
The global drug addiction treatment market has been witnessing steady growth in the recent past owing to the rising prevalence of drug abuse across both developed and developing nations worldwide. In June 2021, according to the United Nations Office on Drugs and Crime (UNODC), around 269 million people worldwide used drugs at least once in 2021. The easy availability of illicit substances coupled with socio-economic vulnerabilities has significantly contributed to the drug addiction crisis. In response, governments across countries have been ramping up efforts to provide evidence-based treatment services to help individuals overcome substance use disorders. This has majorly driven the demand for various pharmacological and psychological addiction treatment drugs and therapies in the global drug addiction treatment market.
Market Dynamics
The key drivers propelling the global drug addiction treatment market growth include growing social acceptance of drug abuse disorders as a medical condition requiring treatment instead of criminalization, increasing healthcare spending by governments to expand treatment facilities, and rising number of opioid analgesic users contributing to the opioid crisis. However, factors such as lack of social support programs post-detoxification, stigma associated with substance abuse treatment, and scarcity of medical professionals with specialized addiction treatment training pose challenges to market players. On the positive side, ongoing research for novel treatment drugs with better safety and efficacy profiles as well as integration of digital technologies in counseling programs present high-growth opportunities for stakeholders.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global drug addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Indivior PLC, Pfizer Inc., Johnson & Johnson, Alkermes, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, GSK Plc., AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Lundbeck A/S, Hikma Pharmaceuticals, Alkermes Plc., Sandoz (a Novartis division), AcelRx Pharmaceuticals, and Nuvectra Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global drug addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug addiction treatment market
Market Segmentation
- By Types Insights (Revenue, USD Billion, 2021 - 2033)
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
- By Treatment Insights (Revenue, USD Billion, 2021 - 2033)
- Therapy
- Medication
- Others
- By Route of Administration Insights (Revenue, USD Billion, 2021 - 2033)
- Oral
- Parenteral
- Others
- By End User Insights (Revenue, USD Billion, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Rehabilitation Center
- Others
- Regional Insights (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Indivior PLC
- Pfizer Inc.
- Johnson & Johnson
- Alkermes
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Addiction Treatment Market, By Types
- Global Drug Addiction Treatment Market, By Treatment
- Global Drug Addiction Treatment Market, By Route of Administration
- Global Drug Addiction Treatment Market, By End User
- Global Drug Addiction Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Addiction Treatment Market, By Types, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Benzodiazepine Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Barbiturate Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
5. Global Drug Addiction Treatment Market, By Treatment, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
6. Global Drug Addiction Treatment Market, By Route of Administration, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
7. Global Drug Addiction Treatment Market, By End User, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Rehabilitation Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
8. Global Drug Addiction Treatment Market, By Region, 2021 - 2033, Value (USD Billion)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Billion)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Billion)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Types, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Treatment, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Billion)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Indivior PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GSK Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lundbeck A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz (a Novartis division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AcelRx Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nuvectra Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
